Alexander B - Search Results

1

Multimodal platform for assessing drug distribution and response in clinical trials.

Lopez BGC, Kohale IN, Du Z, Korsunsky I, Abdelmoula WM, Dai Y, Stopka SA, Gaglia G, Randall EC, Regan MS, Basu SS, Clark AR, Marin BM, Mladek AC, Burgenske DM, Agar JN, Supko JG, Grossman SA, Nabors LB, Raychaudhuri S, Ligon KL, Wen PY, Alexander B, Lee EQ, Santagata S, Sarkaria J, White FM, Agar NYR. Lopez BGC, et al. Among authors: alexander b. Neuro Oncol. 2022 Jan 5;24(1):64-77. doi: 10.1093/neuonc/noab197. Neuro Oncol. 2022. PMID: 34383057 Free PMC article.

2

Targeting DNA repair and the cell cycle in glioblastoma.

Alexander BM, Pinnell N, Wen PY, D'Andrea A. Alexander BM, et al. J Neurooncol. 2012 May;107(3):463-77. doi: 10.1007/s11060-011-0765-4. Epub 2011 Nov 24. J Neurooncol. 2012. PMID: 22113697 Review.

3

Bayesian adaptive randomized trial design for patients with recurrent glioblastoma.

Trippa L, Lee EQ, Wen PY, Batchelor TT, Cloughesy T, Parmigiani G, Alexander BM. Trippa L, et al. J Clin Oncol. 2012 Sep 10;30(26):3258-63. doi: 10.1200/JCO.2011.39.8420. Epub 2012 May 29. J Clin Oncol. 2012. PMID: 22649140 Free PMC article.

4

Importance of extracranial disease status and tumor subtype for patients undergoing radiosurgery for breast cancer brain metastases.

Dyer MA, Kelly PJ, Chen YH, Pinnell NE, Claus EB, Lee EQ, Weiss SE, Arvold ND, Lin NU, Alexander BM. Dyer MA, et al. Among authors: alexander bm. Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):e479-86. doi: 10.1016/j.ijrobp.2012.01.054. Int J Radiat Oncol Biol Phys. 2012. PMID: 22704705

5

A phase II study of conventional radiation therapy and thalidomide for supratentorial, newly-diagnosed glioblastoma (RTOG 9806).

Alexander BM, Wang M, Yung WK, Fine HA, Donahue BA, Tremont IW, Richards RS, Kerlin KJ, Hartford AC, Curran WJ, Mehta MP. Alexander BM, et al. J Neurooncol. 2013 Jan;111(1):33-9. doi: 10.1007/s11060-012-0987-0. Epub 2012 Oct 20. J Neurooncol. 2013. PMID: 23086432 Clinical Trial.

6

Current and future directions for Phase II trials in high-grade glioma.

Alexander BM, Lee EQ, Reardon DA, Wen PY. Alexander BM, et al. Expert Rev Neurother. 2013 Apr;13(4):369-87. doi: 10.1586/ern.12.158. Expert Rev Neurother. 2013. PMID: 23545053 Review.

7

Reply to B. Freidlin et al.

Trippa L, Lee EQ, Wen PY, Batchelor TT, Cloughesy T, Parmigiani G, Alexander BM. Trippa L, et al. J Clin Oncol. 2013 Mar 1;31(7):970-1. doi: 10.1200/JCO.2012.47.4403. J Clin Oncol. 2013. PMID: 23565532 No abstract available.

8

Enhancing radiation therapy for patients with glioblastoma.

Alexander BM, Ligon KL, Wen PY. Alexander BM, et al. Expert Rev Anticancer Ther. 2013 May;13(5):569-81. doi: 10.1586/era.13.44. Expert Rev Anticancer Ther. 2013. PMID: 23617348 Review.

9

Biomarker-based adaptive trials for patients with glioblastoma--lessons from I-SPY 2.

Alexander BM, Wen PY, Trippa L, Reardon DA, Yung WK, Parmigiani G, Berry DA. Alexander BM, et al. Neuro Oncol. 2013 Aug;15(8):972-8. doi: 10.1093/neuonc/not088. Epub 2013 Jul 14. Neuro Oncol. 2013. PMID: 23857706 Free PMC article. Review.

10

Progression-free survival: too much risk, not enough reward?

Alexander BM, Trippa L. Alexander BM, et al. Neuro Oncol. 2014 May;16(5):615-6. doi: 10.1093/neuonc/nou041. Neuro Oncol. 2014. PMID: 24733851 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,789 results

Search Page

Filters